Marc Brisson, PhD
Full Professor

Current research aims to develop and utilise mathematical models to study the natural history and transmission dynamics of infectious disease, and to predict the effectiveness and cost-effectiveness of different control strategies and their impact on health inequalities. The work includes epidemiological analysis, mathematical modelling, valuation of outcomes (i.e. QALYs gained), and economic analysis.

June 2019
WIDESPREAD MEDIA COVERAGE of our article published in The Lancet from local to national to international level (USA, UK, Australia, Spain, France, Norway, Denmark, Sweden, Hungary, Ireland, Argentina, Dominican Republic, Mexico, Kenya, India, Malaysia) [ Media ] [ Media tracking ]
June 2019
PUBLICATION IN THE LANCET! 'Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis' [ TheLancet ]
June 2019
CIHR FUNDING. Marc Brisson is a co-investigator of 3 newly CIHR funded projects :
1) Elimination of cervical cancer through vaccination and screening in high HPV prevalence settings : a mathematical modeling and cost-effectiveness study (Principal Investigator : Mathieu Maheu-Giroux) [CIHR 1] ;
2) Illiap Paanganik Qaujisarniq: Tailoring Cervical Cancer Screening Services for Inuit Women of Nunavik (Principal Investigator: Paul Brassard) [CIHR 2] ;
3) Is Ontario prepared for the return of measles? (Principal Investigator : Shelly Bolotin) [CIHR 3]
June 2019
Our team's work was part of the evidence base that informed the ACIP vote on recommendations to extend HPV vaccination to adults over 26 years of age in the US. [ CDC ]
June 2019
NEW TEAM MEMBERS! Welcome to Léa Drolet Roy and Gabrielle Hudon, research assistants during the summer of 2019.

Admin panel